Phio Pharmaceuticals
PHIO
#10681
Rank
A$17.3 M
Marketcap
A$1.49
Share price
-2.80%
Change (1 day)
-60.86%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -A$16.24 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$12.46 Million a decrease over its 2024 earnings that were of -A$10.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$16.24 Million30.35%
2025 -A$12.46 Million21.65%
2024 -A$10.24 Million-33.96%
2023 -A$15.51 Million-5.7%
2022 -A$16.44 Million-13.6%
2021 -A$19.03 Million51.09%
2020 -A$12.6 Million-1.28%
2019 -A$12.76 Million21.03%
2018 -A$10.54 Million-53.1%
2017 -A$22.48 Million74.49%
2016 -A$12.88 Million-12.02%
2015 -A$14.64 Million16.17%
2014 -A$12.61 Million-57.95%
2013 -A$29.97 Million62.45%
2012 -A$18.45 Million0.87%
2011 -A$18.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.33 Billion 1,994.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26 Million 66.08%๐Ÿ‡บ๐Ÿ‡ธ USA